Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., MiRNA-based therapy for Osteoporosis: MiRNA-125b suppresses the expression of a bone formation inhibitor Sclerostin via down regulation of its target gene, 09/September/2014, 05.53 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: This study suggests, for the first time, that miRNA-125b may inhibit bone formation. Thus, pharmacological formulations encompassing “MiRNA-125b activator” may be used to treat Osteoporosis.